You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Early Bactericidal Activity (EBA)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Tuberculoses, Other Specified Pulmonary Tuberculosis Trial in Cape Town (BTZ-043, Rifafour e-275®, Probe Drug

Completed
  • Pulmonary Tuberculoses
  • Other Specified Pulmonary Tuberculosis
  • Cape Town, South Africa
  • +1 more
Aug 9, 2022

Tuberculosis, Pulmonary Trial in Cape Town (Sanfetrinem Cilexetil, Amoxicillin/clavulanic acid, Rifampicin)

Recruiting
  • Tuberculosis, Pulmonary
  • Sanfetrinem Cilexetil
  • +2 more
  • Cape Town, Western Cape, South Africa
    TASK Clinical Research Centre
May 19, 2022

Tuberculosis Trial in Cape Town (Meropenem Injection, Amoxicillin Clavulanate, Pyrazinamide)

Completed
  • Tuberculosis
  • Meropenem Injection
  • +4 more
  • Cape Town, Western Cape, South Africa
    TASK Clinical Research Centre
Jan 24, 2022

Rifampicin Susceptible Pulmonary Tuberculosis Trial in Cape Town (RESP301, HRZE)

Not yet recruiting
  • Rifampicin Susceptible Pulmonary Tuberculosis
  • Cape Town, Bellville, South Africa
    TASK Clinical Research Centre
Sep 11, 2023

Tuberculosis, Multidrug Resistant Tuberculosis Trial in Paris (Tedizolid arm (SIVEXTRO®), Linezolid arm (ZYVOXID®), Standard

Not yet recruiting
  • Tuberculosis
  • Multidrug Resistant Tuberculosis
  • Tedizolid arm (SIVEXTRO®)
  • +2 more
  • Paris, France
    Bacteriology department- Hôpital Saint-Antoine
Sep 6, 2022

Tuberculosis Trial (GSK3036656, Bedaquiline, Delamanid)

Recruiting
  • Tuberculosis
  • Cape Town, South Africa
    GSK Investigational Site
Jan 24, 2023

Pulmonary Tuberculosis Trial in Beijing (WX-081, Bedaquiline, Standard treatment)

Recruiting
  • Pulmonary Tuberculosis
  • Beijing, Beijing, China
    Beijing Chest Hospital affiliated to Capital Medical University
Dec 14, 2021

Mycobacterium Avium Complex Trial in Baltimore (Azithromycin)

Recruiting
  • Mycobacterium Avium Complex
  • Baltimore, Maryland
    Johns Hopkins University School of Medicine
Mar 7, 2022

Sensitive Pulmonary Tuberculosis Trial in Beijing, Zhengzhou, Jinan (Pyrifazimine (TBI-166))

Active, not recruiting
  • Sensitive Pulmonary Tuberculosis
  • Pyrifazimine (TBI-166)
  • Beijing, Beijing, China
  • +2 more
Sep 14, 2021

Tuberculosis, Pulmonary Trial (Cephalexin, Amoxicillin-Clavulanate 500 Mg-125 Mg Oral Tablet, Standard of care treatment of

Not yet recruiting
  • Tuberculosis, Pulmonary
  • (no location specified)
Dec 15, 2022

Tuberculosis Trial in Cape Town (GSK3036656, RIFAFOUR e-275)

Completed
  • Tuberculosis
  • Cape Town, South Africa
    GSK Investigational Site
Dec 30, 2021

Tuberculosis Trial in Port Au Prince, Bellville (Isoniazid, Vitamin B6)

Completed
  • Tuberculosis
  • Port Au Prince, Haiti
  • +1 more
Mar 16, 2022

Tuberculosis, Pulmonary Trial in Godoy Cruz (RUTI® Vaccine, Placebo)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • RUTI® Vaccine
  • Placebo
  • Godoy Cruz, Mendoza, Argentina
    Hospital José Nestor Lencinas
Jul 26, 2022

Pulmonary Tuberculosis Trial in Cape Town (Meropenem 6g IV over 6 hours, Ertapenem 1g IM, Meropenem 3g IV)

Completed
  • Pulmonary Tuberculosis
  • Meropenem 6g IV over 6 hours
  • +9 more
  • Cape Town, Western Cape, South Africa
    TASK Clinical Research Centre
May 31, 2023

Tuberculosis Trial (RUTI® vaccine, Placebo)

Withdrawn
  • Tuberculosis
  • RUTI® vaccine
  • Placebo
  • (no location specified)
Jul 12, 2022

Tuberculosis Trial in Port-au-Prince (Nitazoxanide, Control)

Completed
  • Tuberculosis
  • Port-au-Prince, Haiti
    Les Centres GHESKIO
Aug 3, 2020

Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB) Trial in Cape Town (BVL-GSK098 9mg, Ethionamide 250mg,

Not yet recruiting
  • Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB)
  • BVL-GSK098 9mg
  • +3 more
  • Cape Town, Western Cape, South Africa
    TASK Clinical Research Centre
Jul 26, 2022

MDR-TB Trial in Shanghai (PRS Regimen V, MDR-TB Treatment Regimen(WHO))

Recruiting
  • MDR-TB
  • PRS Regimen V
  • MDR-TB Treatment Regimen(WHO)
  • Shanghai, China
    Shanghai Pulmonary Hospital
Aug 4, 2022

Pulmonary Tuberculosis Trial (PA-824, Rifafour e-275 mg)

Completed
Has Results
  • Pulmonary Tuberculosis
  • (no location specified)
Sep 4, 2019

Tuberculosis, Pulmonary, Other Specified Pulmonary Tuberculosis Trial in Cape Town, Mbeya, Mwanza (BTZ-043, Bedaquiline,

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Other Specified Pulmonary Tuberculosis
  • Cape Town, South Africa
  • +3 more
Jun 22, 2023

Pulmonary Tuberculosis Trial in Philippines, Singapore, Uganda (Faropenem, Amoxicillin/clavulanic acid, Cefadroxil)

Completed
  • Pulmonary Tuberculosis
  • Cavite, Philippines
  • +5 more
Mar 19, 2020

Tuberculosis Trial (PBTZ169, Isoniazid)

Terminated
Has Results
  • Tuberculosis
  • (no location specified)
Feb 20, 2020

Gastric Cancer Trial in Bialystok (Early postoperative enteral nutrition, based on standard elementary diet (Peptisorb),

Unknown status
  • Gastric Cancer
  • Early postoperative enteral nutrition, based on standard elementary diet (Peptisorb)
  • +3 more
  • Bialystok, Podlaskie, Poland
    Medical University of Bialystok
Mar 16, 2020

Treatment-naïve, Sputum Smear-positive Patients With Drug-sensitive Pulmonary TB Trial in Cape Town (Telacebec (Q203), Rifafour

Completed
  • Treatment-naïve, Sputum Smear-positive Patients With Drug-sensitive Pulmonary TB
  • Telacebec (Q203)
  • Rifafour e-275
  • Cape Town, South Africa
  • +1 more
Sep 9, 2019

Tuberculosis Trial in Ekurhuleni (AZD5847, Ethambutol, isoniazid, pyrazinamide, rifampin)

Completed
  • Tuberculosis
  • AZD5847
  • Ethambutol, isoniazid, pyrazinamide, rifampin
  • Ekurhuleni, Gauteng, South Africa
    Task Clinical Research Centre
Oct 11, 2018